Page 1 of Clinical Trials for Biological Gardasil, 74 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age
Last Updated: May 17, 2012
Condition(s): Cervical Cancer; Papillomavirus Infection
2
Recruiting
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil® Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females
Last Updated: April 26, 2012
Condition(s): Human Papillomavirus (HPV) Type 16/18 Infections
3
Completed
Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil
Last Updated: August 3, 2011
Condition(s): Dose Schedule Study
4
Recruiting
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Last Updated: April 12, 2012
Condition(s): Human Papillomavirus Infection
5
Enrolling by invitation
Evaluation of Long-term HPV Vaccine Efficacy
Last Updated: July 28, 2011
Condition(s): Uterine Cervical Cancer
6
Completed
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents
Last Updated: April 14, 2010
Condition(s): Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Meningitis
7
Recruiting
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Last Updated: April 12, 2012
Condition(s): Vaccines; Meningococcal Vaccines
8
Active, not recruiting
A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)
Last Updated: September 9, 2011
Condition(s): Healthy Papillomavirus Infections
9
Completed
Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents
Last Updated: April 14, 2010
Condition(s): Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Poliomyelitis
10
Recruiting
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Last Updated: October 23, 2011
Condition(s): Arthritis
11
Completed
Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)
Last Updated: April 7, 2010
Condition(s): Cervical Cancer; Genital Warts
12
Enrolling by invitation
Immunogenicity of Gardasil and Twinrix Vaccines Co-administered or Administered a Month Apart and the Effect of a Dose of Gardasil or Cervarix Administered 42 Months Later.
Last Updated: October 20, 2011
Condition(s): Human Papillomavirus
13
Completed
Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)
Last Updated: November 18, 2010
Condition(s): Papillomavirus Infections
14
Active, not recruiting
GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)
Last Updated: April 11, 2012
Condition(s): Papillomavirus Infections
15
Completed
V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)(COMPLETED)
Last Updated: May 13, 2011
Condition(s): HPV Infections
16
Active, not recruiting
Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)(V501-015)
Last Updated: January 4, 2012
Condition(s): Cervical Cancer; Genital Warts
17
Completed
An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)
Last Updated: April 26, 2011
Condition(s): Papillomavirus Infections
18
Recruiting
Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
Last Updated: January 18, 2012
Condition(s): HPV; HIV
19
Completed
Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)
Last Updated: May 20, 2011
Condition(s): Human Papilloma Virus; Cervical Cancer; Vulvar Cancer; Vaginal Cancer; Genital Warts
20
Active, not recruiting
A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501) in Women
Last Updated: June 14, 2010
Condition(s): Healthy; Papillomavirus Infection

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+Gardasil

Page 1 of Clinical Trials for Biological Gardasil, 74 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About